Aptose Biosciences Management
Management criteria checks 2/4
Aptose Biosciences' CEO is William Rice, appointed in Oct 2013, has a tenure of 10.58 years. total yearly compensation is $924.67K, comprised of 67.4% salary and 32.6% bonuses, including company stock and options. directly owns 0.22% of the company’s shares, worth €38.10K. The average tenure of the management team and the board of directors is 1.9 years and 10.6 years respectively.
Key information
William Rice
Chief executive officer
US$924.7k
Total compensation
CEO salary percentage | 67.4% |
CEO tenure | 10.6yrs |
CEO ownership | 0.2% |
Management average tenure | 1.9yrs |
Board average tenure | 10.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | US$925k | US$623k | -US$51m |
Sep 30 2023 | n/a | n/a | -US$49m |
Jun 30 2023 | n/a | n/a | -US$48m |
Mar 31 2023 | n/a | n/a | -US$44m |
Dec 31 2022 | US$2m | US$599k | -US$42m |
Sep 30 2022 | n/a | n/a | -US$56m |
Jun 30 2022 | n/a | n/a | -US$58m |
Mar 31 2022 | n/a | n/a | -US$61m |
Dec 31 2021 | US$2m | US$582k | -US$65m |
Sep 30 2021 | n/a | n/a | -US$56m |
Jun 30 2021 | n/a | n/a | -US$58m |
Mar 31 2021 | n/a | n/a | -US$60m |
Dec 31 2020 | US$12m | US$582k | -US$55m |
Sep 30 2020 | n/a | n/a | -US$48m |
Jun 30 2020 | n/a | n/a | -US$42m |
Mar 31 2020 | n/a | n/a | -US$32m |
Dec 31 2019 | US$2m | US$562k | -US$26m |
Sep 30 2019 | n/a | n/a | -US$25m |
Jun 30 2019 | n/a | n/a | -US$24m |
Mar 31 2019 | n/a | n/a | -US$28m |
Dec 31 2018 | US$2m | US$540k | -US$29m |
Sep 30 2018 | n/a | n/a | -US$26m |
Jun 30 2018 | n/a | n/a | -US$23m |
Mar 31 2018 | n/a | n/a | -US$15m |
Dec 31 2017 | US$983k | US$520k | -US$12m |
Compensation vs Market: William's total compensation ($USD924.67K) is above average for companies of similar size in the German market ($USD394.01K).
Compensation vs Earnings: William's compensation has been consistent with company performance over the past year.
CEO
William Rice (64 yo)
10.6yrs
Tenure
US$924,668
Compensation
Dr. William G. Rice, Ph D., had served as an Independent Director of Oncolytics Biotech Inc. since June 08, 2015 until June 30, 2021. He has been the Chief Executive Officer and President of Aptose Bioscie...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman | 10.6yrs | US$924.67k | 0.22% $ 38.1k | |
Senior VP | 1.9yrs | US$611.37k | 0.047% $ 8.2k | |
Senior VP & Chief Medical Officer | 4.3yrs | US$750.08k | 0.047% $ 8.2k | |
Senior Vice President of Regulatory Affairs | less than a year | no data | no data | |
VP & Controller | 1.3yrs | no data | no data |
1.9yrs
Average Tenure
60yo
Average Age
Experienced Management: LTI's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman | 10.6yrs | US$924.67k | 0.22% $ 38.1k | |
Independent Director | 16.7yrs | US$127.68k | 0.0027% $ 481.3 | |
Independent Director | 1.7yrs | US$132.17k | 0.11% $ 18.9k | |
Lead Independent Director | 16.7yrs | US$172.17k | 0.0092% $ 1.6k | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | 9.4yrs | US$123.67k | 0.21% $ 37.5k | |
Independent Director | 13.1yrs | US$122.68k | 0.0064% $ 1.1k | |
Chairman of Scientific Advisory Board | 10.6yrs | no data | no data | |
Member of Scientific Advisory Board | 9.2yrs | no data | no data | |
Independent Director | 5.8yrs | US$123.67k | 0% $ 0 |
10.6yrs
Average Tenure
70.5yo
Average Age
Experienced Board: LTI's board of directors are seasoned and experienced ( 10.6 years average tenure).